A pharmacy must report the theft or significant loss of which of the following medications to the Drug Enforcement Administration DEA?

Rationale

Carisoprodol is the medication that must be reported to the Drug Enforcement Administration (DEA) in case of theft or significant loss.

Carisoprodol is a muscle relaxant classified as a Schedule IV controlled substance under the Controlled Substances Act, requiring pharmacies to report any theft or loss to the DEA. This regulation is in place to prevent misuse and ensure proper monitoring of controlled substances.

A (Carbamazepine) YOUR ANSWER

Carbamazepine is an anticonvulsant and mood-stabilizing drug, but it is not classified as a controlled substance. Therefore, while pharmacies must keep accurate records of its dispensing, they are not required to report theft or significant loss of this medication to the DEA.

B (Carbidopa) YOUR ANSWER

Carbidopa is used in combination with levodopa to treat Parkinson's disease and is not a controlled substance. As such, there are no DEA reporting requirements for theft or loss of carbidopa, as it is not subject to the same regulations as controlled medications.

C (Carvedilol) YOUR ANSWER

Carvedilol is a non-selective beta-blocker used to treat high blood pressure and heart failure. It is not classified as a controlled substance, so pharmacies do not need to report any theft or significant loss of carvedilol to the DEA.

D (Carisoprodol) CORRECT

Carisoprodol is classified as a Schedule IV controlled substance due to its potential for abuse and dependence. Pharmacies must report any theft or significant loss of this medication to the DEA, aligning with regulatory requirements for controlled substances.

Conclusion

In conclusion, the requirement to report theft or significant loss of medications to the DEA applies specifically to controlled substances. Carisoprodol, being a Schedule IV drug, falls under this category, necessitating adherence to strict reporting guidelines. In contrast, carbamazepine, carbidopa, and carvedilol are not controlled substances, thus exempting them from such reporting obligations.

A pharmacy must report the theft or significant loss of which of the following medications to the Drug Enforcement Administration DEA?

Carisoprodol is the medication that must be reported to the Drug Enforcement Administration (DEA) in case of theft or significant loss.

Related Questions

Related Quizzes

How familiar were you with this question?

Report an Issue

Rate this Practice Test